Cardiovascular, liver, and renal toxicity associated with an intravenous ferric carboxymaltose similar versus the originator compound

BACKGROUND: Ferric carboxymaltose (FCM) is a stable, non-dextran-based intravenous iron complex used to treat iron deficiency of various etiologies. As FCM is a nonbiological complex drug and cannot be fully characterized by physicochemical analyses, it is important to demonstrate in nonclinical mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Toblli, Jorge E, Cao, Gabriel, Rico, Luis, Angerosa, Margarita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716307/
https://www.ncbi.nlm.nih.gov/pubmed/29238166
http://dx.doi.org/10.2147/DDDT.S151162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716307/
https://www.ncbi.nlm.nih.gov/pubmed/29238166
http://dx.doi.org/10.2147/DDDT.S151162

Ejemplares similares